Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndrome

NCT07481422 is registered in ClinicalTrials.gov with University of Rijeka as lead sponsor.

NCT NCT07481422
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07481422 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndrome
Lead sponsor
University of Rijeka
Phase
Phase 1/2
Overall status
Recruiting
Start date
March 15, 2026
Completion date
December 15, 2027
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome (ibs)